KCTD10 and breast neoplasm: Given breast tumor growth was significantly suppressed in an in vivo xenograft model following neddylation blockage and SLC7A11 inhibition, it promoted us to determine whether targeting KCTD10 or USP18 in combination with SLC7A11 inhibition could similarly affect tumor growth in this model.